Sofwave To Participate In Stifel 2024 Healthcare Conference
Date
11/4/2024 8:16:39 AM
(MENAFN- GlobeNewsWire - Nasdaq) SAN CLEMENTE, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced that Louis Scafuri, Chief Executive Officer, and Assaf Korner, Chief financial Officer, will provide a corporate overview and participate in one-on-one investor meetings at the Stifel 2024 Healthcare Conference, to be held in New York from November 18-19, 2024.
Stifel 2024 Healthcare conference
Presentation Format: Corporate overview
Presentation Date: Tuesday, November 19, 2024
Presentation Time: 3:00 p.m. ET
Webcast: Click Here
About Sofwave Medical
Sofwave Medical Ltd. has implemented an innovative approach to wrinkle reduction lifting and cellulite using its proprietary breakthrough technology. SUPERBTM, Synchronous Ultrasound Parallel Beam technology, is FDA-cleared to improve facial lines and wrinkles, lifting the eyebrow and lifting lax submental tissue (beneath the chin), to improve the appearance of skin laxity on the upper arms, as well as the short-term improvement in the appearance of cellulite and treatment of acne scars. The company's Pure ImpactTM module uses EMS technology and is cleared for muscle toning. Sofwave's products provide physicians with smart yet simple, effective, and safe aesthetic solutions for their patients. Contact: ...
Investor Contact:
Brian Ritchie
LifeSci Advisors LLC
(212) 915-2578
...
MENAFN04112024004107003653ID1108848295
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.